Market News: The Knesset group approved a bill to increase deficit ratio's GDP to 7.7%, which will be submitted to the Knesset plenary session for voting.Robot concept stocks are active again and again, and Great Wheel Intelligence, Ningbo Jingda, Kelier and Keli Sensing have reached new heights.The change of industrial metal plate increased the daily limit of Liyuan shares, and the change of industrial metal plate increased the daily limit of Liyuan shares. Yun Aluminum shares rose by more than 7%, and Huafeng Aluminum, Shenhuo, Northern Copper and Yiqiu Resources followed suit.
Shenzhen reports an explosion in a residential building: fire rescue forces have arrived, and Shenzhen Fire Release Report: At 14: 46 on December 11, 2024, Shenzhen Fire Rescue Detachment received an alarm: an alarm occurred in Yuefu Phase II Building, Yuehai Street, Nanshan District, and the command center dispatched 16 fire engines and 80 fire rescue personnel from the first battle force to the scene for disposal, and the full-time command group of Nanshan Brigade was dispatched. At present, fire rescue forces have arrived, and the specific situation needs further verification.Modern Pharmaceuticals: Sinopharm Zhijun, the holding subsidiary, obtained the drug registration certificate of Cefotaxime Tablets. Modern Pharmaceuticals announced that Sinopharm Zhijun Pharmaceutical Co., Ltd., the holding subsidiary, recently received the Drug Registration Certificate of Cefotaxime Tablets approved and issued by National Medical Products Administration. Cefopoxime axetil tablets are the third generation cephalosporins taken orally, which are used to treat upper respiratory tract infections and lower respiratory tract infections caused by sensitive bacteria. In 2023, the global sales of preparations will be USD 370 million, and the sales of public hospitals nationwide will be RMB 102 million. The accumulative R&D investment of Sinopharm Zhijun is about RMB 28.45 million. Obtaining the registration certificate will enrich the company's product line, increase market competitiveness and have a positive impact on the company's future development. However, drug sales are easily affected by factors such as policies and market environment, and there are uncertainties.The Ukrainian military said it attacked the oil depot in the Bryansk region of Russia.
On the 11th, alumina fell by 3.61%, and the latest main contract positions changed as follows. According to the exchange data, as of December 11th, the main contract alumina 2502 closed, with a volume of 174,600 lots. The position data showed that the top 20 seats were net, and the difference position was 10,936 lots. The total turnover of alumina futures contracts was 452,500 lots, an increase of 77,000 lots over the previous day. The first 20 seats in the contract held 264,800 lots, a decrease of 4,558 lots from the previous day. The short positions in the top 20 seats of the contract were 215,500 lots, a decrease of 1,290 lots from the previous day. (Sina Futures)Lexin Technology's daily limit of 20cm today was 192 million yuan, and Lexin Technology's daily limit was 20cm today, with a turnover of 2.799 billion yuan and a turnover rate of 12.22%. After-hours data showed that the special seats of Shanghai Stock Connect bought 215 million yuan and sold 226 million yuan, and the special seats of the two institutions sold 192 million yuan.Meifeng, Sichuan: The wellhead natural gas trial production and recovery project has entered the trial production stage. meifeng, Sichuan announced that the trial production and recovery project of "Jinshi 103 Well" invested and built by Dongcai Shuangrui has completed the joint commissioning, and the trial production LNG products meet the requirements of national standards and are now entering the trial production stage. The total investment of the project is about 70 million yuan, and the main construction content is a set of wellhead gas trial production recovery device with a daily processing capacity of 200,000 m and supporting utilities and auxiliary facilities.